Design and synthesis of substrates for newborn screening of Maroteaux-Lamy and Morquio A syndromes

Bioorg Med Chem Lett. 2010 Oct 15;20(20):5994-6. doi: 10.1016/j.bmcl.2010.08.080. Epub 2010 Aug 25.

Abstract

In continued efforts to develop enzymatic assays for lysosomal storage diseases appropriate for newborn screening laboratories we have synthesized novel and specific enzyme substrates for Maroteaux-Lamy (MPS VI) and Morquio A (MPS IVA) diseases. The sulfated monosaccharide derivatives were found to be converted to product by the respective enzyme in blood from healthy patients but not by blood from patients with the relevant lysosomal storage disease. The latter result shows that the designed substrates are highly selective for the respective enzymes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Infant, Newborn
  • Monosaccharides / chemical synthesis
  • Monosaccharides / chemistry*
  • Monosaccharides / metabolism*
  • Mucopolysaccharidosis IV / diagnosis*
  • Mucopolysaccharidosis IV / enzymology*
  • Mucopolysaccharidosis VI / diagnosis*
  • Mucopolysaccharidosis VI / enzymology*
  • Neonatal Screening / methods*
  • Substrate Specificity
  • Sulfates / chemical synthesis
  • Sulfates / chemistry
  • Tandem Mass Spectrometry / methods

Substances

  • Monosaccharides
  • Sulfates